ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,770.20
0.55%
Dow Jones
42,801.72
0.52%
US Dollar vs MXN
20.26717
0.00%
Brent Oil
70.235
0.00%
Bitcoin
83,694.46
-2.86%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) Noticias

IMRN

Immuron (IMRN)

Immuron Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IMRN
FechaHoraFuenteTítuloSímboloCompañía
07/03/202505:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
05/03/202505:00GlobeNewswire Inc.Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)NASDAQ:IMRNImmuron Ltd
17/01/202505:00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
15/01/202505:00GlobeNewswire Inc.Immuron Announces New Research Collaboration targeting Antimicrobial ResistanceNASDAQ:IMRNImmuron Ltd
14/01/202505:00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Trial UpdateNASDAQ:IMRNImmuron Ltd
06/12/202408:17GlobeNewswire Inc.UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:IMRNImmuron Ltd
06/12/202407:35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
02/12/202405:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thNASDAQ:IMRNImmuron Ltd
21/11/202417:33GlobeNewswire Inc.Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNASDAQ:IMRNImmuron Ltd
16/10/202405:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceNASDAQ:IMRNImmuron Ltd
04/10/202405:30GlobeNewswire Inc.NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyNASDAQ:IMRNImmuron Ltd
01/10/202407:00Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:IMRNImmuron Ltd
05/09/202410:54GlobeNewswire Inc.Immuron Plans Phase 2 Trial for IMM-529 following FDA reviewNASDAQ:IMRNImmuron Ltd
16/08/202405:00GlobeNewswire Inc.Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®NASDAQ:IMRNImmuron Ltd
07/08/202405:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct ConnectNASDAQ:IMRNImmuron Ltd
21/07/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMRNImmuron Ltd
15/07/202407:00GlobeNewswire Inc.Immuron announces record Travelan® sales globally, Australia and USANASDAQ:IMRNImmuron Ltd
02/07/202405:00GlobeNewswire Inc.Immuron requests pre-IND meeting for IMM-529 with FDA filingNASDAQ:IMRNImmuron Ltd
31/05/202405:00GlobeNewswire Inc.Immuron Board ChangesNASDAQ:IMRNImmuron Ltd
31/05/202405:00GlobeNewswire Inc.Immuron CEO Steven Lydeamore to present at Peak Sky HighNASDAQ:IMRNImmuron Ltd
03/05/202405:00GlobeNewswire Inc.Immuron Director ResignationNASDAQ:IMRNImmuron Ltd
15/04/202405:00GlobeNewswire Inc.Immuron to host Live Virtual EventNASDAQ:IMRNImmuron Ltd
10/04/202405:00GlobeNewswire Inc.Immuron Travelan® sales continued strong growthNASDAQ:IMRNImmuron Ltd
07/03/202405:00GlobeNewswire Inc.Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USNASDAQ:IMRNImmuron Ltd
21/02/202405:00GlobeNewswire Inc.Immuron Presentation Australian Biologics Festival 2024NASDAQ:IMRNImmuron Ltd
13/02/202405:00GlobeNewswire Inc.Immuron achieves record Travelan® salesNASDAQ:IMRNImmuron Ltd
08/02/202405:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
16/01/202405:00GlobeNewswire Inc.Immuron achieves record half yearly Travelan® salesNASDAQ:IMRNImmuron Ltd
22/12/202305:00GlobeNewswire Inc.Immuron Clinical Trials UpdateNASDAQ:IMRNImmuron Ltd
04/12/202305:00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

Su Consulta Reciente

NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
CCOM
US500
US 500
CCOM
US30
US 30
NYSE
CVX
Chevron
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
NYSE
KO
Coca Cola
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios